Zydus Lifesciences acquires UK-based LiqMeds Group for Rs.690-Cr

Press Release   BSE Announcement  

Publicly listed Zydus Lifesciences has acquired UK-based LiqMeds Group, which specialises in oral liquid products, for GBP 68 million (INR 690 crores) in an all cash deal. Zydus will pay an upfront consideration of GBP 68 million and yearly earn-outs until 2026 depending on achievement of certain agreed milestones.

Want to receive such news items in your inbox? Click Here to sign up for a trial.

2021 © TSJ Media Pvt Ltd. All rights reserved.